These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15937147)

  • 41. Platelet-activating factor acetylhydrolase: selective inhibition by potent n-alkyl methylphosphonofluoridates.
    Quistad GB; Fisher KJ; Owen SC; Klintenberg R; Casida JE
    Toxicol Appl Pharmacol; 2005 Jun; 205(2):149-56. PubMed ID: 15893542
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of group VI phospholipase A2 isoforms in cardiac endothelial cells.
    Sharma J; Turk J; Mancuso DJ; Sims HF; Gross RW; McHowat J
    Am J Physiol Cell Physiol; 2011 Apr; 300(4):C872-9. PubMed ID: 21191104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.
    Satoh K; Imaizumi T; Kawamura Y; Yoshida H; Hiramoto M; Takamatsu S; Takamatsu M
    J Clin Invest; 1991 Feb; 87(2):476-81. PubMed ID: 1846878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of selective covalent inhibitors of platelet activating factor acetylhydrolase 1B2 from the screening of an oxadiazolone-capped peptoid-azapeptoid hybrid library.
    Sarma BK; Liu X; Kodadek T
    Bioorg Med Chem; 2016 Sep; 24(17):3953-3963. PubMed ID: 27160052
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A sensitive fluorescence-based assay for the detection of ExoU-mediated PLA(2) activity.
    Benson MA; Schmalzer KM; Frank DW
    Clin Chim Acta; 2010 Feb; 411(3-4):190-7. PubMed ID: 19900431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A molecular motif required for the activation of rat neutrophil phospholipase A(2) by organochlorine compounds.
    Olivero J; Bezdecny SA; Ganey PE
    Chem Res Toxicol; 2002 Feb; 15(2):153-9. PubMed ID: 11849040
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased susceptibility to bladder inflammation in smokers: targeting the PAF-PAF receptor interaction to manage inflammatory cell recruitment.
    Marentette J; Kolar G; McHowat J
    Physiol Rep; 2015 Dec; 3(12):. PubMed ID: 26660553
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced breast cancer cell adherence to the lung endothelium via PAF acetylhydrolase inhibition: a potential mechanism for enhanced metastasis in smokers.
    Kispert SE; Marentette JO; McHowat J
    Am J Physiol Cell Physiol; 2014 Nov; 307(10):C951-6. PubMed ID: 25186013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravesical liposome and antisense treatment for detrusor overactivity and interstitial cystitis/painful bladder syndrome.
    Tyagi P; Kashyap MP; Kawamorita N; Yoshizawa T; Chancellor M; Yoshimura N
    ISRN Pharmacol; 2014; 2014():601653. PubMed ID: 24527221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polymorphonuclear leukocytes isolated from umbilical cord blood as a useful research tool to study adherence to cell monolayers.
    Sharma J; Rastogi P; Creer MH; McHowat J
    J Immunol Methods; 2009 Dec; 351(1-2):30-5. PubMed ID: 19800347
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased number of apoptotic endothelial cells in bladder of interstitial cystitis patients.
    Yamada T; Nishimura M; Mita H
    World J Urol; 2007 Aug; 25(4):407-13. PubMed ID: 17554544
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of platelet-activating factor (PAF) acetylhydrolase by methyl arachidonyl fluorophosphonate potentiates PAF synthesis in thrombin-stimulated human coronary artery endothelial cells.
    Kell PJ; Creer MH; Crown KN; Wirsig K; McHowat J
    J Pharmacol Exp Ther; 2003 Dec; 307(3):1163-70. PubMed ID: 14560038
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prostaglandin production in human coronary artery endothelial cells is modulated differentially by selective phospholipase A(2) inhibitors.
    Rastogi P; Beckett CS; McHowat J
    Prostaglandins Leukot Essent Fatty Acids; 2007 Apr; 76(4):205-12. PubMed ID: 17374479
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protease-activated receptor stimulation activates a Ca2+-independent phospholipase A2 in bladder microvascular endothelial cells.
    Rickard A; Portell C; Kell PJ; Vinson SM; McHowat J
    Am J Physiol Renal Physiol; 2005 Apr; 288(4):F714-21. PubMed ID: 15561975
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of platelet-activating factor (PAF) activity in human diseases by phospholipase A2 inhibitors, PAF acetylhydrolases, PAF receptor antagonists and free radical scavengers.
    Peplow PV
    Prostaglandins Leukot Essent Fatty Acids; 1999 Aug; 61(2):65-82. PubMed ID: 10509861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The therapeutic potential of phospholipase A2 inhibitors in cardiovascular disease.
    White MC; McHowat J
    Cardiovasc Hematol Agents Med Chem; 2007 Jan; 5(1):91-5. PubMed ID: 17266551
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neutrophil adherence to bladder microvascular endothelial cells following platelet-activating factor acetylhydrolase inhibition.
    Vinson SM; Rickard A; Ryerse JS; McHowat J
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1241-7. PubMed ID: 15937147
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.